UnitedHealth Group (NYSE:UNH) issued an update on its FY19 earnings guidance on Thursday morning. The company provided EPS guidance of $14.70-14.90 for the period, compared to the Thomson Reuters consensus EPS estimate of $14.71. UnitedHealth Group also updated its FY 2019 guidance to $14.70-14.90 EPS.
Shares of NYSE UNH traded down $3.95 during trading on Friday, reaching $256.65. 4,412,484 shares of the stock were exchanged, compared to its average volume of 3,935,310. The business’s 50-day moving average price is $249.00. UnitedHealth Group has a twelve month low of $208.07 and a twelve month high of $287.94. The company has a quick ratio of 0.73, a current ratio of 0.67 and a debt-to-equity ratio of 0.62. The company has a market cap of $247.66 billion, a P/E ratio of 18.59, a price-to-earnings-growth ratio of 1.39 and a beta of 0.61.
UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, July 18th. The healthcare conglomerate reported $3.60 EPS for the quarter, topping analysts’ consensus estimates of $3.46 by $0.14. UnitedHealth Group had a net margin of 5.51% and a return on equity of 25.20%. The business had revenue of $60.60 billion for the quarter, compared to analysts’ expectations of $60.59 billion. During the same period in the previous year, the company posted $3.14 earnings per share. The business’s revenue for the quarter was up 8.0% compared to the same quarter last year. Equities analysts anticipate that UnitedHealth Group will post 14.71 earnings per share for the current year.
A number of research analysts have recently commented on UNH shares. SunTrust Banks reduced their target price on shares of UnitedHealth Group to $300.00 and set a buy rating on the stock in a research report on Wednesday, April 17th. They noted that the move was a valuation call. Cleveland Research reissued a buy rating on shares of UnitedHealth Group in a research report on Monday, July 15th. Raymond James reissued an average rating on shares of Grupo Aeroportuario dl Srst SAB CV in a research report on Friday. Barclays set a $24.00 price target on shares of Tenet Healthcare and gave the stock a hold rating in a research note on Wednesday, April 17th. Finally, ValuEngine lowered shares of Acceleron Pharma from a strong-buy rating to a buy rating in a research note on Thursday, April 18th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and seventeen have assigned a buy rating to the company. The company has an average rating of Buy and an average price target of $296.56.
In other UnitedHealth Group news, CEO David S. Wichmann bought 20,000 shares of the stock in a transaction on Friday, May 3rd. The stock was purchased at an average price of $231.79 per share, for a total transaction of $4,635,800.00. Following the completion of the purchase, the chief executive officer now directly owns 904,367 shares in the company, valued at $209,623,226.93. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction on Monday, May 6th. The shares were sold at an average price of $239.02, for a total transaction of $1,195,100.00. Following the sale, the director now owns 77,993 shares of the company’s stock, valued at approximately $18,641,886.86. The disclosure for this sale can be found here. In the last 90 days, insiders sold 35,000 shares of company stock valued at $8,392,500. Insiders own 0.87% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Recommended Story: Hedge Funds Explained
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.